Citation Impact
Citing Papers
Criteria, prevalence, and phenotypes of polycystic ovary syndrome
2016
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
2010 Standout
Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments
2014 Standout
Recommendations from the international evidence‐based guideline for the assessment and management of polycystic ovary syndrome
2018 Standout
Glitazones and the management of insulin resistance: what they do and how might they be used
2004
Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis
2010
Abdominal adiposity and the polycystic ovary syndrome
2007
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
2011 Standout
Obesity and androgens: facts and perspectives
2006
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Not all women diagnosed with PCOS share the same cardiovascular risk profiles
2009
Body mass index in relation to semen quality and reproductive hormonesamong 1,558 Danish men
2004 Standout
Functional genetic polymorphisms and female reproductive disorders: Part I: polycystic ovary syndrome and ovarian response
2008
The management of insulin resistance in polycystic ovary syndrome
2007
Polycystic Ovary Syndrome-Epigenetic Mechanisms and Aberrant MicroRNA
2015
Gestational diabetes mellitus
2005 Standout
Evaluation of serum antimullerian hormone and inhibin B concentrations in the differential diagnosis of secondary oligoamenorrhea
2011
Regulatory roles of leptin in reproduction and metabolism: A comparative review
2005
The metabolic syndrome
2010 Standout
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
2018 Standout
The physiology and clinical utility of anti-Müllerian hormone in women
2014 Standout
Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis
2010
Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome
2004
Glucose Metabolism and Insulin Resistance in Women with Polycystic Ovary Syndrome during Therapy with Oral Contraceptives Containing Cyproterone Acetate or Desogestrel
2003
Association of the TNF‐α−308 G/A Promoter Polymorphism with Insulin Resistance in Obesity
2002
A Modern Medical Quandary: Polycystic Ovary Syndrome, Insulin Resistance, and Oral Contraceptive Pills
2003
Inflammation, stress, and diabetes
2005 Standout
Polycystic Ovarian Syndrome: An Evidence-based Approach to Evaluation and Management of Diabetes and Cardiovascular Risks for Today??s Clinician
2007
Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”
2010 Standout
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Clinically useful predictors of conversion to abnormal glucose tolerance in women with polycystic ovary syndrome
2010
Combined oral contraceptives in the treatment of polycystic ovary syndrome
2005
Sex differences in obesity and the regulation of energy homeostasis
2009
Polycystic ovary syndrome and its developmental origins
2007
The Potential Implications of a PCOS Diagnosis on a Woman's Long-Term Health Using Data Linkage
2014
Effects of Race and Family History of Type 2 Diabetes on Metabolic Status of Women with Polycystic Ovary Syndrome
2005
Metabolic and endocrine effects of treatment with peroral or transdermal oestrogens in conjunction with peroral cyproterone acetate in women with polycystic ovary syndrome
2004
Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?
2010
Red meat consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis
2011 Standout
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Metabolic consequences of physical inactivity
2005
Genetic Studies on Polycystic Ovary Syndrome
2016
Acne vulgaris
2011 Standout
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
2011
Polycystic ovary syndrome: a biopsychosocial understanding in young women to improve knowledge and treatment options
2010
Polycystic Ovary Syndrome and Oocyte Developmental Competence
2008
Effect of Perhexiline and Oxfenicine on Myocardial Function and Metabolism During Low-Flow Ischemia/Reperfusion in the Isolated Rat Heart
2000
Fetal Programming of Polycystic Ovary Syndrome by Androgen Excess: Evidence from Experimental, Clinical, and Genetic Association Studies
2006
Polycystic Ovary Syndrome
2005 Standout
Review article: The impact of obesity on reproduction in women with polycystic ovary syndrome
2006
Metformin and gestational diabetes
2003
Phenotypic Expression of Polycystic Ovary Syndrome in South Asian Women
2013
Insulin and insulin resistance:
2004 Standout
Molecular progress in infertility: polycystic ovary syndrome
2002
Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth
2005
Ghrelin and Measures of Satiety Are Altered in Polycystic Ovary Syndrome But Not Differentially Affected by Diet Composition
2004
Exercise therapy in polycystic ovary syndrome: a systematic review
2010
The role of iron in type 2 diabetes in humans
2008
Invited review: Body condition score and its association with dairy cow productivity, health, and welfare
2009 Standout
The Metabolic Syndrome in Polycystic Ovary Syndrome
2007
Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries
2009
Polycystic ovary syndrome: Metabolic consequences and long-term management
2014
Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: A systematic overview and meta-analysis of prospective studies
2007
Polycystic ovary syndrome
1997
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
Type 2 diabetes mellitus
2015 Standout
Polycystic ovarian syndrome in adolescence
2009
Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century
2015 Standout
Testing the Newcastle Ottawa Scale showed low reliability between individual reviewers
2013
Polycystic ovary syndrome
2016 Standout
Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management
2005
Obesity and reproductive disorders in women
2003
Impaired β-cell compensation to dexamethasone-induced hyperglycemia in women with polycystic ovary syndrome
2004
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Early Endocrine, Metabolic, and Sonographic Characteristics of Polycystic Ovary Syndrome (PCOS): Comparison between Nonobese and Obese Adolescents
2003
Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis
2012
Prediabetes: a high-risk state for diabetes development
2012 Standout
Polycystic Ovarian Syndrome (PCOS): A Significant Contributor to The Overall Burden of Type 2 Diabetes in Women
2007
Natural polyphenols: An overview
2016 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
2006 Standout
Role of Follistatin in Promoting Adipogenesis in Women
2009
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
2012
POSITION STATEMENT: Glucose Intolerance in Polycystic Ovary Syndrome—A Position Statement of the Androgen Excess Society
2007
American Association Of Clinical Endocrinologists, American College Of Endocrinology, And Androgen Excess And Pcos Society Disease State Clinical Review: Guide To The Best Practices In The Evaluation And Treatment Of Polycystic Ovary Syndrome - Part 2
2015
Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
2010
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Health Consequences of Obesity in Youth: Childhood Predictors of Adult Disease
1998 Standout
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome
2005
A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome
2008
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose.
2005
Risk of T2DM and impaired fasting glucose among pcos subjects: Results of an 8-year follow-up
2006
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
2015
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Mechanisms of Diabetic Complications
2013 Standout
Glucose Intolerance in a Large Cohort of Mediterranean Women With Polycystic Ovary Syndrome
2004
A Double-Blind, Randomized, Placebo-Controlled Clinical Trial on Benfotiamine Treatment in Patients With Diabetic Nephropathy
2010
The Metabolic Syndrome
2008 Standout
4: Polycystic ovary syndrome
2004
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Genetic Basis of Metabolic Abnormalities in Polycystic Ovary Syndrome
2004
Genetic analysis of candidate genes for the polycystic ovary syndrome
2002
Assessment and management of polycystic ovary syndrome: summary of an evidence‐based guideline
2011
The Metabolic Syndrome: Requiescat in Pace
2005
Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
2012 Standout
Changes in Glucose Tolerance over Time in Women with Polycystic Ovary Syndrome: A Controlled Study
2005
Works of C.R. Milner being referenced
The measurement of erythrocytetransketolase activity on a discreteanalyser
1982
Circulating follistatin concentrations are higher and activin concentrations are lower in polycystic ovarian syndrome
2001
No association between the 308 polymorphism in the tumour necrosis factor alpha (TNFalpha) promoter region and polycystic ovaries
1999
Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome
2001
The in Vivo and in Vitro Effects of Exogenous Leptin on Ovulation in the Rat*
2000
Colorimetric Measurement of Plasma Lactate
1985